CTLA4 and rheumatoid arthritis: In patients with Rheumatoid Arthritis (RA), the abatacept treatment leads to reduced plasmablast counts, decreased frequency of self-reactive memory B cells and curtailed serum lgG (Lorenzetti et al., 2019), suggesting that CTLA-4 help Tregs repress B cells.